<http://schema.org/articleBody>
"&amp;lt;p&amp;gt;\u00A0It can take 15 to 20 years and over 1 billion dollars investment for a neurological drug to get from the laboratory to the pharmacy shelf and much of that time and investment goes towards clinical trials which cannot be successful without enough clinical trial recruitment. This among other motivating factors are considered.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;There are many different types of clinical trials that you can participate in to help increase our understanding of\u00A0Parkinson&amp;amp;#39;s disease and how to treat it. \u00A0These can range from observational trials to treatment trials and are classified as Phase I through Phase IV. Learn more about the types of trials that you may wish to be involved with.&amp;lt;/p&amp;gt;The drug development process heralding a new medication from the laboratory to the pharmacy is a long and tedious journey. \u00A0Learn how an idea becomes a reality - it&amp;amp;#39;s not a simple process, one that spans decades and requires a hefty investment.&amp;lt;p&amp;gt;\u00A0Once you&amp;amp;#39;ve decided to participate in clinical trials, the search begins. How do you find an appropriate clinical study that you qualify for and is in your geographical area? Your options and the resources that are available are explored.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;\u00A0In order to make an informed decision about whether to participate in a clinical trial, you must consider the advantages and disadvantages involved. If and only if the benefits outnumber the downside, should you consider becoming part of a clinical study.&amp;lt;/p&amp;gt;Whether or not to participate in a clinical trial is not an easy decision. \u00A0Are they safe? \u00A0Can I stop once I start? \u00A0What are my rights? \u00A0Do I still see my own doctor? \u00A0These and other questions are explored.&amp;lt;p&amp;gt;When you enter the world of medical research, you may encounter a number of study terms that you may not understand. \u00A0Many of the commonly used ones are defined here.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Lack of clinical trial participation is a real problem in Parkinson&amp;amp;#39;s disease research. \u00A0Part of the problem are the misconceptions or myths about the whole process.\u00A0&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;\u00A0This is the first article in a series, \u201CFrom the Front Lines\u201D which will profile those involved in the field of Parkinson\u2019s disease research in an effort to promote greater understanding of clinical trials and how each of us can contribute to the search for better treatments and a cure.&amp;lt;/p&amp;gt;"^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.verywell.com/your-guide-to-parkinsons-clinical-trials-2612024>